Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
850.00    2.50 (0.30%)
Bid:
815.00
Ask:
850.00
Spread: 35.00 (4.294%)
Market Cap: £138.72m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Pre-Close Trading Update

12 Feb 2020 07:00

RNS Number : 6874C
Arbuthnot Banking Group PLC
12 February 2020
 

12 February 2020

 

ARBUTHNOT BANKING GROUP PLC

 

 

Pre-Close Trading Update

 

Arbuthnot Banking Group PLC ("Arbuthnot" or "the Group") today issues a pre-close trading update ahead of its final results announcement for the year ended 31 December 2019, which is scheduled for 26 March 2020.

 

The Group continued to see good franchise growth during the fourth quarter of 2019 and as a result expects to announce full year pre-tax profits towards the upper end of the range of market expectations.

 

Overall, the Group increased its period-end customer loan balances by 31% on 2018 and deposits by 22% compared to 2018.

 

The planned diversification of the Group's loan book and income streams continued, with Arbuthnot Commercial Asset Based Lending and Arbuthnot Specialist Finance both making good progress in the quarter. Added to this, the Private Bank, Commercial Bank and Renaissance Asset Finance all continued to execute their individual strategies.

 

During the fourth quarter, the Group remained active in its lending markets but, as reported on 16 October in the Group's third quarter update, it was clear that the uncertainty created by the political situation resulted in a number of loan deals being delayed as borrowers waited to see the outcome of the general election.

 

Following the decisive election result, the Group has noticed an increase in the level of confidence in its markets and the pipeline across all business divisions has begun to improve.

 

The directors of the Company accept responsibility for the contents of this announcement.

 

Enquiries:

Arbuthnot Banking Group

0207 012 2400

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

 

Grant Thornton UK LLP (Nominated Adviser and

0207 383 5100

NEX Exchange Corporate Adviser)

Colin Aaronson / Samantha Harrison / Niall McDonald

 

Numis Securities Ltd (Joint Broker)

0207 260 1000

Stephen Westgate

 

Shore Capital (Joint Broker)

0207 408 4090

Hugh Morgan / Daniel Bush

 

Maitland/AMO (Financial PR)

0207 379 5151

Neil Bennett / Sam Cartwright / Jonathan Cook

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUARWRROUUAAR
Date   Source Headline
26th Jul 20181:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'18 results: continuing the good work
17th Jul 20187:00 amRNSHalf Year Report
11th Jul 20187:00 amRNSAppointment of New Chief Executive Officer
10th May 20183:26 pmRNSAGM Statement
17th Apr 20183:23 pmRNSBoard Change
4th Apr 201811:15 amRNSHardman & Co: 2017: capital deployed, adding value
28th Mar 20187:00 amRNSFinal Results
22nd Feb 20187:00 amRNSPre close Trading Update
11th Oct 20177:00 amRNSArbuthnot Banking Group 3Q Trading Update
27th Jul 201711:35 amRNSHardman Research: Value added strategy in results
18th Jul 20177:00 amRNSHalf-year Report
4th May 20173:29 pmRNSAnnual General Meeting Statement - 2017
28th Apr 201711:20 amRNSCompletion of Acquisition
30th Mar 20175:03 pmRNSDirector/PDMR Shareholding
28th Mar 20171:29 pmRNSHardman Research: History is repeating itself
23rd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
21st Feb 20177:00 amRNSPre Close Trading Update
23rd Jan 20175:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20173:27 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:26 pmRNSHardman Research: Clear strategy, value added deal
20th Dec 20165:10 pmRNSAsset Backed Finance Acquisition
19th Dec 20167:00 amRNSLoan Portfolio Acquisition
9th Dec 201611:12 amRNSChange of Adviser
18th Oct 20169:36 amRNSHardman&Co. Special dividend, accelerated investm.
13th Oct 20167:00 amRNSThird Quarter Trading Update
6th Oct 20162:53 pmRNSAppointment of Independent Non-Executive Director
1st Aug 20163:22 pmRNSH&Co: Tripedalism - three legs are better than two
19th Jul 20167:00 amRNSResults for the six months to 30 June 2016
1st Jul 20164:40 pmRNSSecond Price Monitoring Extn
1st Jul 20164:35 pmRNSPrice Monitoring Extension
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
17th Jun 201610:45 amRNSDeclaration of a Special Interim Dividend
15th Jun 20165:36 pmRNSHolding(s) in Company
15th Jun 20165:22 pmRNSCompletion of sale by Arbuthnot Banking Group PLC
15th Jun 20165:16 pmRNSCompletion of sale
14th Jun 20165:06 pmRNSPhantom Share Option Scheme
14th Jun 201611:16 amRNSResults of General Meeting
10th Jun 20162:51 pmRNSAcqusition of West End Premises
10th Jun 201610:46 amRNSAnnouncement of New Independent NED
27th May 20164:30 pmRNSConditional sale of shares by Arbuthnot
27th May 20164:30 pmRNSConditional sale of shares in Secure Trust Bank
27th May 20167:00 amRNSProposed sale of ordinary shares in Secure Trust
27th May 20167:00 amRNSProposed sale by Arbuthnot of ordinary shares
5th May 20163:28 pmRNSAGM Statement
4th May 20163:20 pmRNSAGM Statement
14th Apr 20163:01 pmRNSBoard Changes
13th Apr 20163:47 pmRNSCompletion of the disposal of Everyday Loans Group
29th Mar 20163:58 pmRNSShare Purchase
21st Mar 20161:43 pmRNSShare Acquisition
17th Mar 20167:00 amRNSFinal Results for the year to 31 December 2015

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.